alexa Extended spectrum β-lactamase producing Enterobacteriaceae and antibiotic co-resistance
Infectious Diseases

Infectious Diseases

Journal of Clinical Infectious Diseases & Practice

Author(s): SM Rudresh, T Nagarathnamma

Abstract Share this page

Extended spectrum β-lactamases (ESBLs) are plasmid mediated enzymes inactivating β-lactam antibiotics containing oxyimino group such as oxyimino-cephalosporins and oxyimino-monobactam, except cephamycins and carbapenems1. They are derived from the point mutation of plasmid determined TEM or SHV β-lactamases1,2. ESBLs are inhibited by clavulanic acid and placed under Bush’s functional class 2be3. Till date more than 200 different types of ESBLs have been described. In recent years, there is a dramatic increase in the prevalence of CTX-M type of ESBLs among clinical isolates of Enterobacteriaceae in Europe and Asia.

  • To read the full article Visit
  • Open Access
This article was published in Indian Journal of Medical Research and referenced in Journal of Clinical Infectious Diseases & Practice

Relevant Expert PPTs

Relevant Speaker PPTs

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version